It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Digital approaches are increasingly common in clinical trial recruitment, retention, analysis, and dissemination. Community engagement processes have contributed to the successful implementation of clinical trials and are crucial in enhancing equity in trials. However, few studies focus on how digital approaches can be implemented to enhance community engagement in clinical trials. This narrative review examines three key areas for digital approaches to deepen community engagement in clinical trials—the use of digital technology for trial processes to decentralize trials, digital crowdsourcing to develop trial components, and digital qualitative research methods. We highlight how digital approaches enhanced community engagement through a greater diversity of participants, and deepened community engagement through the decentralization of research processes. We discuss new possibilities that digital technologies offer for community engagement, and highlight potential strengths, weaknesses, and practical considerations. We argue that strengthening community engagement using a digital approach can enhance equity and improve health outcomes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of North Carolina Project-China, Guangzhou, China; Dermatology Hospital of Southern Medical University, Guangzhou, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471); National University of Singapore, Saw Swee Hock School of Public Health, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
2 London School of Hygiene & Tropical Medicine, Clinical Research Department, Faculty of Infectious and Tropical Diseases, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
3 University of North Carolina at Chapel Hill, Department of Medicine, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
4 University of Queensland, School of Social Science, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
5 London School of Hygiene & Tropical Medicine, Department of Infectious Disease Epidemiology, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
6 University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
7 Dermatology Hospital of Southern Medical University, Guangzhou, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471); University of North Carolina at Chapel Hill, Department of Medicine, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
8 University of North Carolina Project-China, Guangzhou, China (GRID:grid.10698.36); London School of Hygiene & Tropical Medicine, Clinical Research Department, Faculty of Infectious and Tropical Diseases, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)